TREATMENT OF CANCERS USING ANTI-EMP2 ANTIBODY AND PD-1/PDL-1 PATHWAY ANTAGONIST COMBINATION THERAPY

摘要

Provided herein are compositions and methods for the treatment of a cancer in a subject having such a cancer (e.g., a breast cancer). In particular, the compositions provided herein include an anti-EMP2 antibody and a PD-1/PD-L1 pathway antagonist.